BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30533178)

  • 1. Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma.
    Gougelet A
    World J Hepatol; 2018 Nov; 10(11):785-789. PubMed ID: 30533178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of serum exosomal microRNAs in hepatocellular carcinoma.
    Jun L; Yang G; Zhisu L
    Biomed Pharmacother; 2019 Mar; 111():1221-1227. PubMed ID: 30841435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer.
    Bullock MD; Silva AM; Kanlikilicer-Unaldi P; Filant J; Rashed MH; Sood AK; Lopez-Berestein G; Calin GA
    Noncoding RNA; 2015 Jun; 1(1):53-68. PubMed ID: 29861415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells.
    Guay C; Menoud V; Rome S; Regazzi R
    Cell Commun Signal; 2015 Mar; 13():17. PubMed ID: 25880779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
    Li S; Yao J; Xie M; Liu Y; Zheng M
    J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
    Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
    Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.
    Pascut D; Pratama MY; Vo NVT; Masadah R; Tiribelli C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.
    Han Q; Zhao H; Jiang Y; Yin C; Zhang J
    Cells; 2019 Jun; 8(6):. PubMed ID: 31181729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma.
    Tang J; Li Y; Liu K; Zhu Q; Yang WH; Xiong LK; Guo DL
    Minerva Med; 2018 Feb; 109(1):15-23. PubMed ID: 28750499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNAs in hepatocellular carcinoma.
    Liu C; Wu H; Mao Y; Chen W; Chen S
    Cancer Cell Int; 2021 May; 21(1):254. PubMed ID: 33964930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional role of exosome in hepatocellular carcinoma.
    Liu H; Li B
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2085-2095. PubMed ID: 30062486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.
    Zhao Z; Zhao G; Yang S; Zhu S; Zhang S; Li P
    Cancer Cell Int; 2021 Jul; 21(1):364. PubMed ID: 34243775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma.
    Xia H; Huang Z; Liu S; Zhao X; He R; Wang Z; Shi W; Chen W; Li Z; Yu L; Huang P; Kang P; Su Z; Xu Y; Yam JWP; Cui Y
    Front Oncol; 2021; 11():653846. PubMed ID: 33869059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.